Radiofrequency renal denervation was associated with significant blood pressure reduction among individuals with chronic kidney disease.

Urinary albumin-creatinine ratio (UACR) may be slightly better than urinary protein-creatinine ratio (UPCR) at predicting kidney failure-related clinical outcomes in chronic kidney disease (CKD), a ...

National implementation of a race-neutral eGFR equation contributed to more modifications and higher kidney transplantation rates for Black candidates, according to study data published in the Journal ...

In EGFR-mutated non-small cell lung cancer Tagrisso with pemetrexed and chemotherapy was associated with an improvement in survival. Clinical trial results have shown that among patients with locally ...

As one of our Adviser Intel contributors, Anthony Martin, says: "With savings, it's not the amount that matters the most, but the consistency." In his article on how to save for big goals, he goes on ...

First-line aumolertinib plus platinum-pemetrexed chemotherapy significantly improved progression-free survival (PFS) compared with aumolertinib alone in certain patients with epidermal growth factor ...

A combination of iza-bren (BL-B01D1), a novel bispecific antibody-drug conjugate (ADC), with osimertinib demonstrated a 100% objective response rate (ORR) in patients with first-line EGFR-mutated ...

Thinking of getting an electric vehicle? E.V.s tend to be pricier than comparable gas cars, but they have lower maintenance costs. And charging with electricity is typically cheaper than stopping at ...

1 Institut Supérieur des Sciences de la Santé (INSSA), Nazi Boni University, Bobo-Dioulasso, Burkina Faso. 2 Unité de Formation et de Recherche en Sciences de la Santé (UFR-SDS), Joseph Ki-Zerbo ...

The FDA has granted accelerated approval to sunvozertinib (Zegfrovy, Dizal Pharmaceutical) for locally advanced or metastatic non-small cell lung cancer (NSCLC) with epidermal growth factor receptor ( ...

Datroway received FDA accelerated approval for EGFR-mutated NSCLC after progression on EGFR-targeted therapy and platinum-based chemotherapy. Clinical trials showed a 45% overall response rate and a ...